The ROE as of December 2024 (TTM) for OptiNose, Inc. (OPTN) is 46.18%

According to OptiNose, Inc.’s latest financial reports and current stock price. The company's current ROE is 46.18%. This represents a change of 337.34% compared to the average of 10.56% of the last 4 quarters.

OptiNose, Inc. (OPTN) Historical ROE (quarterly & annually)

How has OPTN ROE performed in the past?

The mean historical ROE of OptiNose, Inc. over the last ten years is -186.78%. The current 46.18% ROE has changed -124.73% with respect to the historical average. Over the past ten years (40 quarters), OPTN's ROE was at its highest in in the March 2021 quarter at 156.31%. The ROE was at its lowest in in the December 2020 quarter at -351.56%.

OptiNose, Inc. (OPTN) ROE by Quarter and Year

Discovering the peaks and valleys of OptiNose, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OptiNose, Inc. (OPTN) Average ROE

How has OPTN ROE performed in the past?

The current ROE of OptiNose, Inc. (OPTN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

OptiNose, Inc. (OPTN) ROE vs. Peers

How is OPTN’s ROE compared to its peers?

OptiNose, Inc.’s ROE is less than Collegium Pharmaceutical, Inc. (40.81%), less than Phibro Animal Health Corporation (6.59%), greater than ANI Pharmaceuticals, Inc. (-1.60%), less than Procaps Group S.A. (97.17%), greater than Silver Spike Investment Corp. (0%), less than Lifecore Biomedical, Inc. (17.23%), less than Kamada Ltd. (6.34%), greater than Shuttle Pharmaceuticals Holdings, Inc. (-582.98%), greater than Cumberland Pharmaceuticals Inc. (-40.17%), greater than Ironwood Pharmaceuticals, Inc. (-7.63%), less than Amphastar Pharmaceuticals, Inc. (22.92%), less than Eagle Pharmaceuticals, Inc. (17.39%), less than Alkermes plc (26.49%), greater than Evolus, Inc. (-966.29%), less than Prestige Consumer Healthcare Inc. (12.35%), greater than Regencell Bioscience Holdings Limited (-48.12%), less than Neurocrine Biosciences, Inc. (15.68%), greater than Intra-Cellular Therapies, Inc. (-9.93%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Dynavax Technologies Corporation (3.19%),

Build a custom stock screener for OptiNose, Inc. (OPTN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OptiNose, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OptiNose, Inc. (OPTN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OptiNose, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.